Cardiac magnetic resonance predictors of adverse outcomes in Chagas cardiomyopathy
Frontiers in Cardiovascular Medicine · 17.03.2026 · 13
DOI: 10.3389/fcvm.2026.1758594 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 17.03.2026. Verfasst von Nicolás Ariza-Ordóñez und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chagas cardiomyopathy (CC) is a major cause of cardiac morbidity and mortality in Latin America. The disease presents with varying degrees of myocardial involvement, posing a significant clinical challenge. Multimodal imaging plays a crucial role in patient assessment and management; however, the role of cardiac magnetic resonance (CMR) imaging in this context remains under investigation.
Objective
To evaluate the association between CMR-derived parameters and the occurrence of adverse outcomes in patients with CC.
Methods
Patients with CC underwent comprehensive CMR evaluation using a 1.5-T scanner. Imaging assessments included biventricular volumes, left ventricle ejection fraction (LVEF), right ventricle ejection fraction (RVEF) and late gadolinium enhancement (LGE) for scar analysis. Follow-up data were collected to assess a primary composite outcome comprising all-cause mortality, cardiovascular hospitalization, ischemic stroke, and heart transplantation. All-cause mortality was analyzed as a secondary outcome.
Results
A total of 133 patients were included [median age 64 years, 71 (53.4%) female]. The mean LVEF was 43.3% ± 15%. LV scar was detected in 97% of patients. Myocardial edema, LV aneurysm, and LV thrombus were observed in 21.1%, 21.1%, and 12.8% of patients, respectively. The primary composite outcome occurred in 63 patients (47.4%). In multivariable analysis, age, subendocardial LV scarring, and extensive LV scar (≥6 segments with LGE) were independently associated with the primary outcome. Only age was independently associated with all-cause mortality.
Conclusions
In patients with CC, subendocardial LV scarring and extensive myocardial fibrosis (≥6 segments with LGE) were independently associated with adverse clinical outcomes. These CMR-derived parameters may serve as valuable prognostic indicators in this high-risk population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
- Cardiology Department, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.
- Radiology Department, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.
- Department of Cardiovascular Medicine, McGill University Health Centre, Montreal, QC, Canada.
- Pediatric Cardiology and Adult Congenital Heart Disease Institute, Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.
- Department of Cardiology, Baylor Scott and White, Round Rock, TX, United States.
Zitieren
APA
Ariza-Ordóñez, N., Rangel, D., Valderrama-Achury, M. D., Pino Marín, A., Forero, J. F., Jaimes, C., Guerrero-Chalela, C. E., Chetrit, M., & Medina, H. M. (2026). Cardiac magnetic resonance predictors of adverse outcomes in Chagas cardiomyopathy. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1758594
Vancouver
Ariza-Ordóñez N, Rangel D, Valderrama-Achury MD, Pino Marín A, Forero JF, Jaimes C, et al. Cardiac magnetic resonance predictors of adverse outcomes in Chagas cardiomyopathy. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1758594
BibTeX
@article{ArizaOrdez2026,
author = {Ariza-Ordóñez, Nicolás and Rangel, Diego and Valderrama-Achury, Maria Daniela and Pino Marín, Antonia and Forero, Julián F and Jaimes, Claudia and Guerrero-Chalela, Carlos Eduardo and Chetrit, Michael and Medina, Héctor M},
title = {Cardiac magnetic resonance predictors of adverse outcomes in Chagas cardiomyopathy},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1758594}
}
EUVIMED